Brain Neoplasms  >>  Torisel (temsirolimus)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Torisel (temsirolimus) / Pfizer
NCT00016328: CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme

Completed
2
33
US
temsirolimus, CCI-779, cell cycle inhibitor 779, Torisel, laboratory biomarker analysis, pharmacological study, pharmacological studies
National Cancer Institute (NCI)
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
08/05
 
NCT00335764: Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Checkmark In combination with sorafenib for recurrent glioblastoma or gliosarcoma
Jun 2013 - Jun 2013: In combination with sorafenib for recurrent glioblastoma or gliosarcoma
Checkmark P1/2 data
Oct 2012 - Oct 2012: P1/2 data
Completed
1/2
92
US
sorafenib tosylate, BAY 43-9006, BAY 43-9006 Tosylate Salt, BAY 54-9085, Nexavar, SFN, erlotinib hydrochloride, CP-358,774, erlotinib, OSI-774, tipifarnib, R115777, Zarnestra, temsirolimus, CCI-779, cell cycle inhibitor 779, Torisel
National Cancer Institute (NCI)
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
02/10
09/12
NCT00112736: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma

Checkmark Erlotinib & temsirolimus for pts with recurrent malignant gliomas
Jan 2014 - Jan 2014: Erlotinib & temsirolimus for pts with recurrent malignant gliomas
Completed
1/2
69
US
erlotinib, CP-358,774, erlotinib hydrochloride, OSI-774, temsirolimus, CCI-779, cell cycle inhibitor 779, Torisel, therapeutic conventional surgery, laboratory biomarker analysis, pharmacological study, pharmacological studies
National Cancer Institute (NCI)
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Adult Pilocytic Astrocytoma, Adult Pineal Gland Astrocytoma, Adult Subependymal Giant Cell Astrocytoma, Recurrent Adult Brain Tumor
04/10
04/14
NCT00329719: Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma

Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Checkmark P1/2 data
Oct 2012 - Oct 2012: P1/2 data
Checkmark P2 data
More
Completed
1/2
115
US
Conventional Surgery, Laboratory Biomarker Analysis, Sorafenib Tosylate, BAY 43-9006 Tosylate, BAY 54-9085, Nexavar, sorafenib, Temsirolimus, CCI-779, CCI-779 Rapamycin Analog, Cell Cycle Inhibitor 779, Rapamycin Analog, Rapamycin Analog CCI-779, Torisel
National Cancer Institute (NCI)
Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Neoplasm
02/13
02/13

Download Options